Skip to main content

Dr. Len Calabrese - EULAR 2018 Vasculitis Update on C5a Receptor Inhibitor

Jun 20, 2018 4:34 pm
EULAR studies on avacopan (CCX168), an oral selective C5a receptor inhibitor

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×